Doctors Note Logo

Published on: 6/15/2026

Low-Dose Naltrexone: Why Physicians Are Using It Off-Label for Autoimmune Disease, Fibromyalgia, and More

Low-dose naltrexone (LDN), prescribed off-label at 1.5–4.5 mg nightly, is gaining attention as a treatment for autoimmune conditions like multiple sclerosis and Crohn's disease, as well as fibromyalgia and chronic pain disorders. LDN works by modulating the immune system and reducing inflammation, offering pain relief with minimal side effects. Current research and patient reports show modest but meaningful gains in pain reduction, fatigue, and overall quality of life, though larger trials and dosing standards are still needed.

Key considerations include mechanism of action, dosing protocols, qualifying conditions, and safety factors—each of which can influence your next healthcare decision.

If you're experiencing chronic pain, fatigue, or symptoms suggestive of an autoimmune condition, identifying the underlying cause is the critical first step before exploring treatments like LDN. A free, instant, online symptom check can help you clarify your symptoms, understand possible conditions, and decide whether LDN or another approach is worth discussing with your doctor. It takes only minutes, requires no signup fees, and gives you actionable insight to guide your next steps confidently.

Reviewed for medical accuracy: 06/15/2026

answer background

Explanation

Low-Dose Naltrexone: Why Physicians Are Using It Off-Label for Autoimmune Disease, Fibromyalgia, and More

Low-dose naltrexone (LDN) has gained attention in recent years as an off-label option for managing a range of chronic conditions, including autoimmune diseases and fibromyalgia. While standard-dose naltrexone (50 mg daily) is FDA-approved for treating opioid and alcohol dependence, LDN typically uses doses between 1.5 mg and 4.5 mg at bedtime. This lower dosage appears to tap into naltrexone's immune-modulating and pain-modulating properties without blocking endorphins around the clock.

Below, we'll explore what low-dose naltrexone is, how it might work, which conditions physicians are prescribing it for, and what the research says. We'll also cover safety considerations and practical tips for anyone thinking about LDN.


What Is Low-Dose Naltrexone?

  • Standard naltrexone: An opioid antagonist approved for addiction treatment at 50 mg–100 mg per day.
  • Low-dose naltrexone (LDN): Doses ranging from 1.5 mg to 4.5 mg, typically taken once nightly.
  • Off-label use: Prescribing a drug for conditions not listed on its official label, based on emerging evidence and clinical judgment.

Because naltrexone is a well-known, generic medication with a long history of safety in addiction medicine, physicians have been comfortable exploring its use at lower doses for other health challenges.


How Might Low-Dose Naltrexone Work?

Exact mechanisms are still under study, but leading theories include:

  1. Opioid receptor "rebound"

    • Brief opioid receptor blockade at night may trigger an increase in endorphin and enkephalin production the next day, supporting pain relief and immune regulation.
  2. Immune modulation

    • LDN may reduce pro-inflammatory cytokines (chemical messengers) and shift immune cells toward a less inflammatory state.
  3. Glial cell regulation

    • In the central nervous system, LDN may calm overactive glial cells that contribute to chronic pain and neuroinflammation.

Off-Label Uses of Low-Dose Naltrexone

Physicians report prescribing LDN for a variety of conditions, including:

  • Autoimmune diseases

    • Multiple sclerosis (MS)
    • Crohn's disease and ulcerative colitis
    • Rheumatoid arthritis
    • Hashimoto's thyroiditis
  • Chronic pain disorders

    • Fibromyalgia
    • Complex regional pain syndrome (CRPS)
    • Chronic back pain
  • Neurological conditions

    • Long-term Lyme disease symptoms
    • Chronic fatigue syndrome (myalgic encephalomyelitis)
  • Other inflammatory conditions

    • Psoriasis
    • Interstitial cystitis (painful bladder syndrome)

What Does the Research Say?

While large-scale trials are limited, a growing number of small studies, case series, and randomized controlled trials suggest:

  • Fibromyalgia
    • A placebo-controlled trial found that 4.5 mg of LDN reduced daily pain by about 30% in patients with fibromyalgia.
  • Crohn's disease
    • A pilot study showed that 4.5 mg LDN led to clinical improvement in nearly 89% of participants, with some achieving remission.
  • Multiple sclerosis
    • Open-label studies report improvements in quality of life and spasticity.

Overall, most studies report modest but meaningful benefits, few adverse events, and improved patient-reported outcomes. However, larger multicenter trials are still needed to confirm efficacy and optimal dosing.


Potential Benefits of Low-Dose Naltrexone

Patients and clinicians may choose LDN for:

  • Reduced pain intensity and better pain control
  • Improved fatigue levels and daytime energy
  • Enhanced mood and sleep quality
  • Fewer flare-ups in autoimmune conditions
  • A low-cost, generic medication with minimal drug interactions

Many people report that LDN "fills the gap" when traditional therapies aren't enough, or when they wish to minimize reliance on steroids or high-dose immunosuppressants.


Safety and Side Effects

Low-dose naltrexone has a favorable safety profile. Common side effects are usually mild and transient:

  • Vivid dreams or sleep disturbances
  • Headache
  • Digestive upset (nausea, constipation)
  • Irritability (rare)

Because LDN briefly blocks opioid receptors, it's critical not to take opioid pain medications within 24–48 hours of LDN dosing. Always inform your doctor about all medications you're using.


Who Might Consider Low-Dose Naltrexone?

LDN may be an option if you:

  • Have an autoimmune or chronic pain condition that isn't fully controlled by standard therapies
  • Want to reduce reliance on steroids, biologics, or high-dose immunosuppressants
  • Experience significant fatigue, pain, or flares despite current treatment
  • Are looking for a medication with a low side-effect profile
  • Are willing to work closely with a physician familiar with off-label prescribing

If you're experiencing widespread pain, fatigue, and other symptoms that aren't fully explained, try our free Fibromyalgia symptom checker to better understand what might be happening and guide your conversation with your doctor.


Getting Started: Practical Tips

  1. Find a knowledgeable provider

    • Look for a rheumatologist, neurologist, or pain specialist experienced with LDN.
  2. Start low, go slow

    • Typical initiation: 1.5 mg nightly, increasing by 0.5 mg every 1–2 weeks up to 4.5 mg.
  3. Timing matters

    • Take LDN at bedtime on an empty stomach to optimize absorption and reduce interference with daytime endorphin activity.
  4. Monitor and adjust

    • Keep a symptom diary to track pain levels, sleep quality, fatigue, and mood.
    • Report any side effects promptly so your doctor can fine-tune your dose.
  5. Combine with lifestyle strategies

    • Gentle exercise, stress management (meditation, yoga), and an anti-inflammatory diet can complement LDN's effects.

Conclusion

Low-dose naltrexone is an emerging off-label therapy for a variety of chronic and autoimmune conditions. With a growing body of small clinical studies and a long history of safety in addiction medicine, LDN offers hope for people with fibromyalgia, multiple sclerosis, Crohn's disease, and more. While not a cure-all, many patients experience meaningful improvements in pain, fatigue, and quality of life.

Before starting LDN, it's essential to speak to a doctor—especially if you have a serious or life-threatening condition, or you're taking other medications. Your physician can help you weigh the potential benefits and risks, guide dosing, and monitor your progress.

Remember, your health journey is unique. If you're exploring fibromyalgia as a possibility, don't hesitate to use our free Fibromyalgia symptom checker and discuss the results with your healthcare provider.

(References)

  • * Younger J, Parkitny L, McLain A. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014 Apr;33(4):451-9. doi: 10.1007/s10067-013-2495-2. Epub 2014 Jan 25. PMID: 24464739; PMCID: PMC3962576.

  • * Patten DK, Patel K, Cooper A, et al. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation. Ther Adv Chronic Dis. 2021 Mar 18;12:2040622321995392. doi: 10.1177/2040622321995392. PMID: 33777416; PMCID: PMC7977468.

  • * Mattioli G, Cacciapuoti F. The role of low-dose naltrexone in chronic pain management: A review. J Pain Res. 2022 Dec 15;15:3953-3962. doi: 10.2147/JPR.S386187. PMID: 36544838; PMCID: PMC9764516.

  • * Bolton M, Ng F, Parkitny L, Younger J. The effect of low-dose naltrexone on quality of life in subjects with fibromyalgia: a randomized controlled trial. Pain Med. 2016 May;17(5):910-9. doi: 10.1093/pm/pnw038. Epub 2016 Apr 19. PMID: 27101235; PMCID: PMC4895015.

  • * Smith JP, Melton GB, Tillie JM, et al. Low-dose naltrexone in the treatment of Crohn's disease: a small randomized, double-blind, placebo-controlled trial. Dig Dis Sci. 2013 Aug;58(8):2333-41. doi: 10.1007/s10620-013-2615-z. Epub 2013 Mar 15. PMID: 23494726; PMCID: PMC3693247.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.